ADMINISTRATION

Chapman T.W. Playing second fiddle.  Fitting into the future is the biggest challenge. Hosp Health Netw. 1996; 70(20): 32-3.

McGuire C. Contributions and challenges of medical education research. Acad Med. 1996; 71(10): S121-126.

Tabbara I.A.; Ghazal C.D.; Ghazal H.H. Early drop in protein C and antithrombin III is a predictor for the development of venoocclusive disease in patients undergoing hematopoietic stem cell transplantation. J Hematother. 1996; 5(1): 79-84.

top

ANATOMY

Batni S.; Scalzetti L.; Moody S.A.; Knox B.E. Characterization of the xenopus rhodopsin gene. J Biol Chem. 1996; 271(6): 3179-86.

Bauer D.V.; Best D.W.; Hainski A.M.; Moody S.A. A contact dependent animal-to-vegital signal biases neural lineages during xenopus cleavage stages. Dev Biol. 1996; 178(2): 217-228.

Delarue M.; Johnson K.E.; Boucaut J.C. Anteroposterior segregation of superficial and deep cells during gastrulation in pleurodeles waltl and rana pipiens embryos. J Exper Zool. 1996; 276(5): 345-360.

Hainski A.M.; Moody S.A. Activin-like signal activates dorsal-specific maternal RNA between 8- and 16-cell stages of Xenopus. Dev Genet. 1996; 19(3): 210-21.

Krum J.M. Effect of astroglial degeneration on neonatal blood-brain barrier marker expression. Exp Neurol. 1996; 142(1): 29-35.

Moody S.A.; Bauer D.V.; Hainski A.M.; Huang S. Determination of Xenopus cell lineage by maternal factors and cell interactions. Curr Top Dev Biol. 1996; 32: 103-38.

Moody S.A.; Miller V.; Spanos A.; Frankfurter A. Developmental expression of a neuron-specific beta-tubulin in frog (Xenopus laevis): a marker for growing axons during the embryonic period. J Comp Neurol. 1996; 364(2): 129-30.

Neilson K.M.; Friesel R. Ligand independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains. J Biol Chem. 1996; 271(40): 25049-25057.

Peusner K.D.; Giaume C. Dendritic growth and changes in electrophysiological properties during development of chick vestibular neurons. Ann N Y Acad Sci. 1996; 781: 677-9.

Rosenstein J.M. Permeability of the blood-brain barrier to protein and [3H]GABA in introparenchymal fetal CNS tissue grafts. Exp Neurol. 1996; 143(1): 66-79.

Rosenstein J.M.; Krum J.M. Cytoskeletel protein immunoexpression in fetal neural grafts: distribution of phosphorylated and nonphosphorylated neurofilament protein and microtubule-associated protein 2 (MAP-2). Cell Transplant. 1996; 5(2): 233-41.

Smotrich D.B.; Stillman R.J.; Widra E.A.; Gindoff P.R.; Kaplan P.; Graubert M. Johnson K.E. Immunocytochemical localization of growth factors and their receptors in human pre-embryos and Fallopian tubes. Hum Reprod. 1996; 11(1): 184-90.

Stepp M.A.; Zhu L.; Cranfill R. Changes in beta 4 integrin expression and localization in vivo in response to corneal epithelial injury. Invest Ophthalmol Vis Sci. 1996; 37(8): 1593-601.

Walsh R.J.; Weglicki W.B.; Correa de Araujo R. Distribution of specific substance P binding sites in the heart and adjacent great vessels of the Wistar white rat. Cell Tissue Res. 1996; 284(3): 95-500.

Winkles J.A.; Alberts G.F.; Peifley K.A.; Nomoto K.; Liau G.; Majesky M.A.  Postnatal regulation of fibroblast growth-factor ligand and receptor gene-expression in rat thoracic aorta. Am J Pathol. 1996; 149(6): 2119-2131.

top

ANESTHESIOLOGY

Becker R.B.; Zimmerman J.E. ICU scoring systems allow prediction of patient outcomes and comparison of ICU performantce [Review]. Crit Care Clin. 1996; 12(3): 503-14.

Chin M.L. Regional anesthestic techniques for chronic pain management.  Lefkowitz M.; Lebovitz A.H., Eds. A practical approach to pain management.  1996; : 65-90. Boston Little, Brown and Co. RB127 P72 1996.

Jayes R.L.; Zimmerman J.E.; Wagner D.P.; Knaus W.A. Variations in the use of do-not-resuscitate orders in ICUs.  Findings from a national study. Chest. 1996; 110(5): 1332-9.

Knaus W.A. The use of severity scoring in clinical investigations of seriously ill patients. IN: Evans T.W.; Hinds C.J., Eds. Recent advances in critical care medicine. New York: Churchill Livingstone; 1996; 4: 191-212.  RC 86.7 R42 V.4 1996.

Knaus W.A.; Harrell F.E. Jr.; LaBrecque J.F.; Wagner D.P.; Pribble J.P.; Draper E.A.; Fisher C.J. Jr.; Soll L. Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in epsis.  The rhIL-1ra Phase III Sepsis Syndrome Study Group. Crit Care Med. 1996; 24(1): 46-56.

Ostheimer G.W; Leavitt K.A. Epidural anesthesia: technique. IN: Van Zundert A.; Ostheimer G.W., Eds. Pain relief and anesthesia in obstetrics. New York: Churchill Livingtone; 1996: 288-295.  RG732 P14 1996.

Ostheimer G.W; Leavitt K.A. Spinal anesthesia: technique. IN: Van Zundert A.; Ostheimer G.W., Eds. Pain relief and anesthesia in obstetrics. New York: Churchill Livingtone; 1996: 400-406.
RG732 P14 1996.

Pollack M.M.; Patel K.M.; Ruttimann U.; Cuerdon T. Frequency of variable measurement in 16 pediatric intensive care units: influence on accuracy and potential for bias in severity of illness assessment. Crit Care Med. 1996; 24(1): 74-7.

Pollack M.M.; Patel K.M.; Ruttimann U.E. PRISM III: an update Pediatric Risk of Mortality score. Crit Care Med. 1996; 24(5): 743-52.

Seneff M.G. Arterial line placement and care. IN: Rippe J.M.; Irwin R.S.; Fink M.P.; Cerra F.B., Eds. Medicine. 3rd ed. Boston: Little, Brown and Co.; 1996: 36-47.  RC86.7 I55 1996.

Seneff M.G. Central venous catheters. IN: Rippe J.M.; Irwin R.S.; Fink M.P.; Cerra F.B., Eds. Medicine. 3rd ed. Boston: Little, Brown and Co.; 1996: 15-36.  RC86.7 I55 1996.

Seneff M.G.; Zimmerman J.E.; Knaus W.A.; Wagner D.P.; Draper E.A.  Predicting the duration of mechanical ventilation. The importance of disease and patient characteristics. Chest. 1996; 110(2): 469-97.

Sun X.; Haking R.B.; Knaus W.A.; Muir J.F. Prognosis of acute respiratory failure in patients with chronic obstructive pulmonary disease. IN: Derenne J.P.; Whitelaw W.A.; Similowski T., Eds. Acute respiratory failure in chronic obstructive pulmonary disease. New York: Marcel Dekker, Inc.; 1996: 559-576. RC776 R4 A28 1996.

Sun X.; Wagner D.P.; Knaus W.A. Does selective decontamination of the digestive tract reduce mortality for severly ill patients? Crit Care MEd. 1996; 24(5): 753-5.

Wick C.E.; Loew M.H.; Kurantin-Mills J. Evaluation of microvessels of the conjunctiva. Am J Physiol. 1996; 40(3): H1229-H1239.

Zimmerman J.E. Managing the internal evaluation process. IN: Sibbald W.J.; Massaro T.A.; McLeod D.M., Eds. The business of critial care: A textbook for clinicians who manage special care units. Armonk, NY: Futura Publ.; 1996: 167-198.  RA975.5 I56 B87 1996.

Zimmerman J.E.; Knaus W.A.; Sun X.; Wagner D.P. Severity stratification and outcome prediction for multisystem organ failure and dysfunction [Review]. World J Surg. 1996; 20(4): 401-5.

Zimmerman J.E.; Wagner D.P.; Seneff M.G.; Backer R.B.; Sun X.; Knaus W.A. Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival. epatology. 1996; 23(6): 1393-401.

top

BIOCHEMISTRY AND MOLECULAR BIOLOGY

Bailey J.M.; Nelson K.A. Inhibition of HIV-1 replication by uridine-3'spiroxirane, a new type of reverse transcriptase inhibitor. Biochem Soc Trans. 1996; 24(2): 245s.

Bieberich C.J.; Fujita K.; He W.W.; Jay G. Prostate specific and androgen dependent expression of a novel homeobox gene. J Biol Chem. 1996; 271(50): 31779-31782.

Donohue P.J.; Feng, S. L. Y.; Alberts G.F.; Guo Y.; Peifley K.A.; Hsu D.K.W.; Winkles J.A. Fibroblast growth factor I stimulation of quiescent NIH 3T3 cells increases G/T mismatch binding protein expression. Biochem J. 1996; 319(10): 9-12.

Ellerby L.M.; Ellerby H.M.; Park S.M.; Testa M.P.; Holleran A.L.; Murphy A.N.; Fiskum G.; Kane D.J.; Testa M.P.; Kayalar C.; Bredesen D.E. Shift of the cellular oxidation reduction potential in neural cells expressing Bcl-2. J Neurochem. 1996; 67(3): 1259-67.

Fiskum G., Ed. Neurodegenerative diseases: Molecular and cellular mechanisms and therapeutic advances. New York: Plenum Press; 1996.  RC365 N47 1996.

Goldstein A.L.; Sarin P.S.; Garaci E. Thymic hormones in the treatment of AIDS and other infectious diseases. IN: Gupta S., Ed. Immunology of HIV infection. New York: Plenum Medical Book; 1996: 513-524.  RC607 A26 I45 1996.

Hof P.R.; Bogaert Y.E.; Rosenthal R.E.; Fiskum G. Distribution of neuronal populations containing neurofilament protein and calcium-binding proteins in the canine neocortex: regional analysis and cell typology. J Chem Neuroanat. 1996; 11(2): 81-98.

Hof P.R.; Rosenthal R.E.; Fiskum G. Distribution of neurofilament protein and calcium: binding proteins parvalbumin, calbindin, and calretinin in the canine hippocampus. J Chem Neuroanat. 1996; 11(1): 1-12.

Hof P.R.; Vissavajjhala P.; Rosenthal R.E.; Fiskum G.; Morrison J.H. Distribution of glutamate receptor subunit proteins Glur2(4), Glur5/6/7, and Nmdar1 in the canine and primate cerebral cortex - a comparative immunohistochemical analysis. Brain Research. 1996; 723(1-2): 77-89.

Hsu D.K.W.; Guo Y.; Alberts G.F.; Copeland N.G.; Gilbert D.J.; Jenkins N.A.; Peifley K.A.; Winkles J.A. Identification of a murine tef-1-related gene expressed after mitogenic stimulation of quiescent fibroblasts and during myogenic differentiation. J Biol Chem. 1996; 271(23): 13786-95.

Kirkley J.E.; Goldstein A.L.; Naylor P.H. Adjuvant properties of montanide CsA-720 with a recombinant HIV P17 GAG protein and synthetic peptide antigens.  Scan J Immunol. 1996; 43(4): 431-8.

Levy E.I.; Paino J.E.; Sarin P.S.; Goldstein A.L.; Caputy A.J.; Wright D.C.; Sekhar L.N. Enzyme linked immunosorbent assay quatification of cytokine concentrations in human meningiomas. Neurosurgery. 1996; 39(4): 823-828.

Moody T.W.; Getz R.; Rosenstein J.M. Autoradiographic distribution of bombesin/gastrin-releasing peptide receptors in fetal cortex transplants. Exp Neurol. 1996; 142(1): 195-201.

Moody T.W.; Zia F.; Venugopal R.; Fagarasa M.; Lie H.; Hu V. Grp receptors are present in non-small cell lung cancer cells. J Cell Biol. 1996; S24(247-56).

Murphy A.N.; Bredesen D.E.; Cortopassi G.; Wang E.; Fiskum G. Bel-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci USA. 1996; 93(18): 9893-8.

Rounseville M.P.; Lin H.C.; Agbottah E.; Shukla R.R.; Rabson A.B.; Kumar A. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem. Virology. 1996; 216(2): 411-7.

Sreenath T.L.; Pollack R.A.; Bieberich C.J. Functional specificity of hoxa-4 in vertebral patterning lies outside of the homeodomain. Proc Natl Acad Sci USA. 1996; 93(18): 9636-40.

Vanderhoek J.Y., Ed. Frontiers in bioactive lipids. New York: Plenum Press; 1996.  QP 751 F89 1996.

Winkles J.A.; Alberts G.F.; Peifley K.A.; Nomoto K.; Liau G.; Majesky M.A. Postnatal regulation of fibroblast growth-factor ligand and receptor gene-expression in rat thoracic aorta. Am J Pathol. 1996; 149(6): 2119-2131.

top

COMPUTER MEDICINE

Knaus W.A. The use of severity scoring in clinical investigations of seriously ill patients. IN: Evans T.W.; Hinds C.J., Eds. Recent advances in critical care medicine. New York: Churchill Livingstone; 1996; 4: 191-212.  RC 86.7 R42 V.4 1996.

Pincetl P. Colorectal cancer. IN: Rakel R.E., Ed. Saunders manual of medical practice. Philadelphia: W.B. Saunders Co.; 1996: 332-333.  RC55 S325 1996.

Rochon J. Analyzing bivariate repeated measures for discrete and continuous outcome variables. Biometrics. 1996; 52(2): 740-50.

top

DERMATOLOGY

Elgart M.L. Insect bites and stings. IN: Arndt K.A.; LeBoit P.E.; Robinson J.K.; Wintroub B.U., Eds. Cutaneous medicine and surgery: an integrated program in dermatology. Philadelphia: W.B. Saunders; 1996; 1 & 2: 818-822.  RL71 .C94 1996.

Elgart M.L. A risk-benefit assessment of agents used in the treatment of scabies [Review]. Drug Saf. 1996; 14(6): 386-93.

Elgart M.L. Tinea incognito: an update on Majocci granuloma [Review]. Dermatol Clin. 1996; 14(1): 51-55.

Elgart M.L. Unusual subcutaneous infections [Review]. Dermatol Clin. 1996; 14(1): 105-11.

Elgart M.L. Zygomycosis [Review]. Dermatol Clin. 1996; 14(1): 141-146.

Masri-Fridling G.D. Dermatophytosis of the feet [Review]. Dermatol Clin. 1996; 14(1): 33-40.

Noonan F.P.; Webber L.J.; De Fabo E.C.; Hoffman H.A.; Bendich A.; Mathews-Roth M. Dietary beta-carotene and ultraviolet-induced immunosuppression. Clin Exp Immunol. 1996; 103(1): 4-60.

Prussick R. Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy. Sem Cutaneous Med Surg. 1996; 15(4): 267-276.

Prussick R.; Horn T.D.; Wilson W.H.; Turner M.C. A characteristic eruption associated with ifosfamide, caroplatin, and etoposide chemotherapy after pretreatment with recombinant interleukin-1a. J Am Acad Dermatol. 1996; 35(5 )(pt 1): 705-710.

Warren N.G. Actinomycosis, nocardiosis, and actinomycetoma [Review].  Dermatol Clin. 1996; 14(1): 85-95.

Warren N.G. Taxonomy and introduction. Dermatol Clin. 1996; 14(1): 1-7.

Wortman P.D.; Kalter D.C. Nocardiosis and actinomycosis. IN: Arndt K.A.; LeBoit P.E.; Robinson J.K.; Wintroub B.U., Eds. Cutaneous medicine and surgery: an integrated program in dermatology. Philadelphia: W.B. Saunders; 1996; 1 & 2: 1006-1010. RL71 .C94 1996.

top

The George Washington University